Annual Cash & Cash Equivalents
$8.29 B
+$1.76 B+27.00%
December 31, 2024
Summary
- As of February 24, 2025, ELV annual cash & cash equivalents is $8.29 billion, with the most recent change of +$1.76 billion (+27.00%) on December 31, 2024.
- During the last 3 years, ELV annual cash & cash equivalents has risen by +$3.41 billion (+69.84%).
- ELV annual cash & cash equivalents is now at all-time high.
Performance
ELV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.29 B
+$422.00 M+5.36%
December 31, 2024
Summary
- As of February 24, 2025, ELV quarterly cash and cash equivalents is $8.29 billion, with the most recent change of +$422.00 million (+5.36%) on December 31, 2024.
- Over the past year, ELV quarterly cash and cash equivalents has increased by +$1.79 billion (+27.57%).
- ELV quarterly cash and cash equivalents is now -24.10% below its all-time high of $10.92 billion, reached on September 30, 2023.
Performance
ELV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.0% | +27.6% |
| 3 y3 years | +69.8% | +27.6% |
| 5 y5 years | +67.9% | +27.6% |
ELV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.8% | -24.1% | +69.8% |
| 5 y | 5-year | at high | +69.8% | -24.1% | +108.0% |
| alltime | all time | at high | +468.8% | -24.1% | +2173.2% |
Elevance Health Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $8.29 B(+27.0%) | $8.29 B(+5.4%) |
| Sep 2024 | - | $7.87 B(+21.1%) |
| Jun 2024 | - | $6.50 B(+4.4%) |
| Mar 2024 | - | $6.23 B(-4.6%) |
| Dec 2023 | $6.53 B(-11.7%) | $6.53 B(-40.2%) |
| Sep 2023 | - | $10.92 B(+9.3%) |
| Jun 2023 | - | $9.99 B(-1.5%) |
| Mar 2023 | - | $10.14 B(+37.3%) |
| Dec 2022 | $7.39 B(+51.4%) | $7.39 B(-16.7%) |
| Sep 2022 | - | $8.87 B(+37.4%) |
| Jun 2022 | - | $6.46 B(+4.8%) |
| Mar 2022 | - | $6.16 B(+26.3%) |
| Dec 2021 | $4.88 B(-15.0%) | $4.88 B(-11.1%) |
| Sep 2021 | - | $5.49 B(+4.4%) |
| Jun 2021 | - | $5.26 B(-43.6%) |
| Mar 2021 | - | $9.33 B(+62.4%) |
| Dec 2020 | $5.74 B(+16.3%) | $5.74 B(+44.1%) |
| Sep 2020 | - | $3.98 B(-33.9%) |
| Jun 2020 | - | $6.03 B(+12.8%) |
| Mar 2020 | - | $5.34 B(+8.3%) |
| Dec 2019 | $4.94 B(+25.5%) | $4.94 B(+17.8%) |
| Sep 2019 | - | $4.19 B(+2.7%) |
| Jun 2019 | - | $4.08 B(-9.0%) |
| Mar 2019 | - | $4.48 B(+13.9%) |
| Dec 2018 | $3.93 B(+9.0%) | $3.93 B(-7.7%) |
| Sep 2018 | - | $4.26 B(-9.0%) |
| Jun 2018 | - | $4.68 B(+1.1%) |
| Mar 2018 | - | $4.63 B(+28.3%) |
| Dec 2017 | $3.61 B(-11.4%) | $3.61 B(-40.8%) |
| Sep 2017 | - | $6.10 B(+33.7%) |
| Jun 2017 | - | $4.56 B(-32.7%) |
| Mar 2017 | - | $6.77 B(+66.2%) |
| Dec 2016 | $4.08 B(+92.8%) | $4.08 B(+60.1%) |
| Sep 2016 | - | $2.55 B(+60.9%) |
| Jun 2016 | - | $1.58 B(-5.6%) |
| Mar 2016 | - | $1.68 B(-20.7%) |
| Dec 2015 | $2.11 B(-1.8%) | $2.11 B(+36.5%) |
| Sep 2015 | - | $1.55 B(-0.3%) |
| Jun 2015 | - | $1.55 B(+11.2%) |
| Mar 2015 | - | $1.40 B(-35.1%) |
| Dec 2014 | $2.15 B(+36.0%) | $2.15 B(+25.3%) |
| Sep 2014 | - | $1.72 B(-3.7%) |
| Jun 2014 | - | $1.78 B(-9.5%) |
| Mar 2014 | - | $1.97 B(+24.6%) |
| Dec 2013 | $1.58 B | $1.58 B(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $2.19 B(+62.2%) |
| Jun 2013 | - | $1.35 B(-19.1%) |
| Mar 2013 | - | $1.67 B(-32.7%) |
| Dec 2012 | $2.48 B(+12.4%) | $2.48 B(+1.4%) |
| Sep 2012 | - | $2.44 B(+25.0%) |
| Jun 2012 | - | $1.95 B(-14.3%) |
| Mar 2012 | - | $2.28 B(+3.5%) |
| Dec 2011 | $2.20 B(+23.1%) | $2.20 B(-12.2%) |
| Sep 2011 | - | $2.51 B(+47.6%) |
| Jun 2011 | - | $1.70 B(-29.2%) |
| Mar 2011 | - | $2.40 B(+34.3%) |
| Dec 2010 | $1.79 B(-62.9%) | $1.79 B(-11.8%) |
| Jun 2010 | - | $2.03 B(-42.5%) |
| Mar 2010 | - | $3.53 B(-26.8%) |
| Dec 2009 | $4.82 B(+120.5%) | $4.82 B(+161.4%) |
| Sep 2009 | - | $1.84 B(+6.8%) |
| Jun 2009 | - | $1.72 B(-27.5%) |
| Mar 2009 | - | $2.38 B(+8.9%) |
| Dec 2008 | $2.18 B(-21.1%) | $2.18 B(-3.8%) |
| Sep 2008 | - | $2.27 B(-0.1%) |
| Jun 2008 | - | $2.27 B(-10.9%) |
| Mar 2008 | - | $2.55 B(-7.8%) |
| Dec 2007 | $2.77 B(+6.4%) | $2.77 B(-2.0%) |
| Sep 2007 | - | $2.82 B(-32.8%) |
| Jun 2007 | - | $4.21 B(+23.6%) |
| Mar 2007 | - | $3.40 B(+30.7%) |
| Dec 2006 | $2.60 B(-5.0%) | $2.60 B(+16.7%) |
| Sep 2006 | - | $2.23 B(+15.3%) |
| Jun 2006 | - | $1.93 B(-9.6%) |
| Mar 2006 | - | $2.14 B(-21.9%) |
| Dec 2005 | $2.74 B(+88.0%) | $2.74 B(+26.7%) |
| Sep 2005 | - | $2.16 B(+10.8%) |
| Jun 2005 | - | $1.95 B(+31.0%) |
| Mar 2005 | - | $1.49 B(+2.3%) |
| Dec 2004 | $1.46 B | $1.46 B(+105.1%) |
| Sep 2004 | - | $710.60 M(-34.8%) |
| Jun 2004 | - | $1.09 B(+58.9%) |
| Mar 2004 | - | $686.30 M(+2.4%) |
| Sep 2003 | - | $670.10 M(+40.8%) |
| Jun 2003 | - | $475.90 M(+2.6%) |
| Mar 2003 | - | $463.90 M(-49.1%) |
| Sep 2002 | - | $912.00 M(+37.0%) |
| Jun 2002 | - | $665.70 M(+45.9%) |
| Mar 2002 | - | $456.30 M(+25.2%) |
| Sep 2001 | - | $364.60 M |
FAQ
- What is Elevance Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Elevance Health?
- What is Elevance Health annual cash & cash equivalents year-on-year change?
- What is Elevance Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Elevance Health?
- What is Elevance Health quarterly cash and cash equivalents year-on-year change?
What is Elevance Health annual cash & cash equivalents?
The current annual cash & cash equivalents of ELV is $8.29 B
What is the all time high annual cash & cash equivalents for Elevance Health?
Elevance Health all-time high annual cash & cash equivalents is $8.29 B
What is Elevance Health annual cash & cash equivalents year-on-year change?
Over the past year, ELV annual cash & cash equivalents has changed by +$1.76 B (+27.00%)
What is Elevance Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELV is $8.29 B
What is the all time high quarterly cash and cash equivalents for Elevance Health?
Elevance Health all-time high quarterly cash and cash equivalents is $10.92 B
What is Elevance Health quarterly cash and cash equivalents year-on-year change?
Over the past year, ELV quarterly cash and cash equivalents has changed by +$1.79 B (+27.57%)